Pharmacological characteristics and species‐related variations of β3‐adrenergic receptors
- 6 May 1995
- journal article
- review article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 9 (3) , 211-218
- https://doi.org/10.1111/j.1472-8206.1995.tb00288.x
Abstract
Beta-adrenergic receptors (beta-AR) belong to the large multigenic family of receptors coupled to GTP-binding proteins. Three subtypes have been identified: beta 1-, beta 2- and beta 3-AR. Much of the work delineating the precise pharmacological comparison of the three beta-ARs has come from investigations with stably transfected Chinese hamster ovary cells (CHO cells). This review discusses the structure and function of beta 3-AR in various species and presents new findings on a number of beta 3-AR ligands including carazolol, tertatolol and CL 316,243 which were found to be selective and potent beta 3-AR agonists and ZD 2079 and salmeterol which appear to display full but non-subtype selective agonistic activity. Species-related variations of the beta 3-AR pharmacology have been shown for propranolol and bupranolol. With the ongoing characterization of the beta 3-AR at the molecular and cellular level, and with the advent of computer-assisted molecular modelling to aid in the determination of the three-dimensional structure of the receptor, it is thought that novel beta 3-AR compounds will become available with improved selectivity and potency.Keywords
This publication has 46 references indexed in Scilit:
- Carazolol: a potent, selective β3-adrenoceptor agonistEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Molecular Cloning and Pharmacological Characterization of the Bovine beta3-adrenergic ReceptorEuropean Journal of Biochemistry, 1995
- Noradrenaline-serotonin interactions in the anxiolytic effects of 5-HT1A agonistsBehavioural Pharmacology, 1994
- The pharmacology of salmeterolLife Sciences, 1993
- Molecular cloning of a human β3‐adrenergic receptor cDNAFEBS Letters, 1993
- Overview of Clinical Safety and Efficacy of TertatololCardiology, 1993
- Mechanism of Action of Bucindolol in Human Ventricular MyocardiumJournal of Cardiovascular Pharmacology, 1990
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988
- Investigations on the exogenous influencing of the spontaneous tumour rate in ratsExperimental pathology, 1986
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967